Oxygen free radicals and systemic autoimmunity

Clinical and Experimental Immunology

Volumn 131, Issue 3, 2003, Pages 398-404

  Ahsan, H ^a,b   Ali, A ^a,c   Ali, Rashid ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Anti DNA antibodies; Apoptosis; Autoantibodies; ROS; SLE; Systemic autoimmunity

Indexed keywords

8 HYDROXYGUANOSINE; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; DNA ANTIBODY; DOUBLE STRANDED DNA; ERYTHROCYTE ANTIGEN; GUANOSINE DERIVATIVE; HISTONE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; OXYGEN RADICAL; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DERMATOMYOSITIS; DISEASE ACTIVITY; DNA DAMAGE; DNA STRAND BREAKAGE; GLOMERULUS; GOODPASTURE SYNDROME; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNE COMPLEX DISEASE; IMMUNOGENICITY; LUPUS ERYTHEMATOSUS NEPHRITIS; MIXED CONNECTIVE TISSUE DISEASE; OXIDATIVE STRESS; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; IMMUNITY, CELLULAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; REACTIVE OXYGEN SPECIES;

EID: 0037340645     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02104.x     Document Type: Review

References (98)

1. Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219:1-14.
2. Grisham MB. Reactive metabolites of oxygen and nitrogen in biology and medicine. Austin: RG Landes Co., 1992.
3. Nappi AJ, Vass E. Hydroxyl radical formation via iron-mediated Fenton Chemistry is inhibited by methylated catechols. Biochim Biophys Acta 1998; 1425:159-67.
4. Maddipati KR, Marnett LJ. Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem 1987; 262:17398-403.
5. Lloyd RV, Hanna PM, Mason RP. The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Rad Biol Med 1997; 22:885-8.
6. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Rad Biol Med 1995; 18:321-36.
7. Ward JF, Evans JW, Limoli CL, Calabro-Jones PM. Radiation and hydrogen peroxide induced free radical damage to DNA. Br J Cancer 1987; 55:105-12.
8. Mates JM, Gomez CP, Blanca M. Chemical and biological activity of free radical scavengers in allergic diseases. Clin Chim Acta 2000; 296:1-15.
9. Arouma OI. Free radicals and food. Chem Br 1993; 29:210-4.
10. Linn S. DNA damage by iron and hydrogen peroxide in vitro and in vivo. Drug Metab Rev 1998; 30:313-26.
11. Ha HC, Sirisoma NS, Kuppusamy P, Zweier JL, Woster PM, Casero RA. The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci USA 1998; 95:11140-5.
12. Halliwell B, Vitamin C. poison, prophylactic or panacea? Trends Biochem Sci 1999; 24:255-9.
13. Melov S, Schneider JA, Day BJ et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1998; 18:159-63.
14. 2 for platelet-derived growth factor signal transduction. Science 1995; 270:296-9.
15. Kaouass M, Deloyer P, Gouders I, Peulen O, Dandrifosse G. Role of interleukin-1 beta, interleukin-6 and TNF-alpha in intestinal maturation induced by dietary spermine in rats. Endocrine 1997; 6:187-94.
16. Kagaya K, Miyakawa Y, Watanabe K, Fukazawa Y. Antigenic role of stress-induced catalase of Salmonella typhimurium in cell mediated immunity. Infect Immun 1992; 60:1820-5.
17. Tsai KJ, Hung IJ, Chow CK, Stern A, Chao SS, Chin DTY. Impared production of nitric oxide, superoxide and hydrogen peroxide in glucose 6-phosphate dehydrogenase-deficient granulocytes. FEBS Lett 1998; 436:411-4.
18. Chen C, Zhou J, Xu H, Jiang Y, Zhu G. Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model. Biol Trace Elem Res 1997; 59:187-93.
19. Galan P, Preziosi P, Monget AL. Effects of trace elements and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long hospitalized subjects. Int J Vit Nutr Res 1997; 67:450-60.
20. DeWaart FG, Portengen L, Doekes G, Verwaal CJ, Kok FJ. Effect of 3 months vitamin E supplementation on indices of the cellular and humoral immune response in elderly subjects. Br J Nutr 1997; 78:761-4.
21. Chen F, Lu Y, Demers LM et al. Role of hydroxyl radical in silica-induced NF-kappa B activation in macrophages. Ann Clin Lab Sci 1998; 28:1-13.
22. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998; 68:447-63.
23. 2 and NO and antioxidant enzyme activities of rat neutrophils in culture. Cell Biochem Funct 1998; 16:43-9.
24. Levinson SS. Humoral mechanisms in autoimmune disease. J Clin Immunoassay 1994; 17:72-84.
25. Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J Rheumatol 1991; 18:1511-9.
26. Fritzler MJ, Ali R, Tan EM. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix. J Immunol 1984; 132:1216-22.
27. Rokeach L, Hoch SO. B-cell epitopes of Sm autoantigens. Mol Biol Rep 1992; 16:165-74.
28. Reichlin M, Harley JB. Antibodies to Ro (SSA) and the heterogeneity of systemic lupus erythematosus. J Rheumatol 1987; 14:112-7.
29. Dixit K, Ali R. Antigen binding characteristics of antibodies induced against nitric oxide modified plasmid DNA. Biochim Biophys Acta 2001; 1528:1-8.
30. Islam N, Ali R. Immunological studies on DNA-lysine photoadduct. Biochem Mol Biol Int 1998; 45:453-64.
31. Tasneem S, Ali R. Binding of SLE autoantibodies to native poly(I), ROS-poly(I) and native DNA. A comparative study. J Autoimmunity 2001; 17:199-205.
32. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993; 362:709-15.
33. Alam K, Ali R. Human anti-DNA autoantibodies and induced antibodies against ROS-modified DNA show similar antigen binding characteristics. Biochem Mol Biol Int 1999; 47:881-90.
34. Ara J, Ali R. Polynucleotide specificity of anti-ROS DNA antibodies. Clin Exp Immunol 1993; 94:134-9.
35. Naparstek Y. The role of autoantibodies in autoimmune disease. Annu Rev Immunol 1993; 11:79-104.
36. Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science 1988; 240:1302-9.
37. Lunec J, Herbert K, Blount S, Griffiths HR, Emery P. 8-hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 1994; 348:131-8.
38. Bashir S, Harris G, Denman M, Blake DR, Winyard PG. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993; 52:659-66.
39. Ashok BT, Ali R. Binding of human anti-DNA autoantibodies to reactive oxygen species modified DNA and probing oxidative DNA damage in cancer using monoclonal antibody. Int J Can 1998; 78:404-9.
40. Joenje H. Genetic toxicology of oxygen. Mutat Res 1989; 219:193-208.
41. Stich HF, Anders F. The involvement of reactive oxygen species in oral cancers of betel quid/tobacco chewers. Mutat Res 1989; 214:47-61.
42. Meneghini R. Genotoxicity of active oxygen species in mammalian cells. Mutat Res 1988; 195:215-30.
43. Ashok BT, Ali R. The aging paradox: free radical theory of aging. Exp Gerontol 1999; 34:293-303.
44. Ames BN. Endogenous oxidative DNA damage, aging and cancer. Free Rad Res Commun 1989; 7:121-8.
45. Marx JL. Oxygen free radicals linked to many diseases. Science 1987; 235:529-31.
46. Halliwell B, Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett 1987; 213:9-14.
47. Naparstek Y, Madaio MP. Are DNA antibodies actually pathogenic? Lupus 1997; 6:307-9.
48. 2 or gamma irradiation is dependent on the mechanism of ·OH radical production. Br J Cancer 1988; 58:34-7.
49. Lunec J, Griffiths HR, Blake DR. Oxygen free radicals in inflammation. ISI Atlas Sci 1987; 1:45-58.
50. Stollar BD, Anti DNA antibodies. Clin Immunol Allergy 1981; 1:243-59.
51. Pisetsky DS. Antinuclear antibodies. Diagn Lab Immunol 1994; 14:371-85.
52. Swaak T, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody. Ann Rheum Dis 1985; 44:245-51.
53. Isenberg D, Shoenfeld Y. The origin and significance of anti-DNA antibodies. Immunol Today 1987; 8:279-81.
54. Tan EM. Autoantibody to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 1982; 33:167-240.
55. Pollard KM, Jones JE, Tan EM, Theofilopoulos AN, Dixon FJ, Rubin RL. Polynucleotide specificity of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol 1986; 40:197-208.
56. Tasneem S, Ali R. Antigenicity of poly(I) and ROS-poly(I) and their recognition of human anti-DNA autoantibodies. Immunol Invest 2001; 30:335-45.
57. Arif Z, Ali R. Antigenicity of poly(dA-dT) poly(dA-dT) photo-crosslinked with 8-methoxypsoralen. Arch Biochem Biophys 1996; 329:191-8.
58. Ahmad J, Ashok BT, Ali R. Reactive oxygen species modified thymine and poly(dT) represent unique epitope for human anti-DNA autoantibodies. Immunol Lett 1997; 58:69-74.
59. Stollar BD. Immunochemistry of DNA. Int Rev Immunol 1989; 5:1-22.
60. Blount S, Griffiths HR, Lunec J. Reactive oxygen species induce antigenic changes in DNA. FEBS Lett 1989; 245:100-4.
61. Ahmad R, Alam K, Ali R. Antigen binding characteristics of antibodies against hydroxyl radical modified thymidine monophosphate. Immunol Lett 2000; 71:111-5.
62. Ashok BT, Ali R. Antigen binding characteristics of experimentally-induced antibodies against hydroxyl radical modified native DNA. Autoimmunity 1999; 29:11-9.
63. Ashok BT, Ahmad J, Qadri A, Ali R. Anti-ROS-DNA monoclonal antibody as molecular probe for DNA damage. Biochem Mol Biol Int 1997; 43:1219-29.
64. Blount S, Griffiths HR, Lunec J. Reactive oxygen species damage to DNA and its role in systemic lupus erythematosus. Mol Asp Med 1991; 12:93-105.
65. Blount S, Griffiths HR, Lunec J. Reactive oxygen species modified human DNA eliciting a more discriminating antigen for the diagnosis of systemic lupus erythematosus. Clin Exp Immunol 1990; 81:384-9.
66. Ahmad J, Ashok BT, Ali R. Detection of oxidative DNA damage by a monoclonal antibody: role of lysyl residues in antigen binding. Immunol Lett 1998; 62:87-92.
67. Ashok BT, Ali R. Binding of circulating antibodies to reactive oxygen species modified-DNA and detecting DNA damage by a monoclonal antibody probe. Mech Ageing Dev 1998; 103:69-80.
68. Wu DP, Gilkeson GS, Armitage J, Reich CE, Pisetsky DS. Selective recognition of DNA antigenic determinants by murine monoclonal anti-DNA antibodies. Clin Exp Immunol 1990; 82:33-7.
69. Hardin JA. The lupus autoantigens and the pathogenesis of SE. Arth Rheum 1986; 29:457-61.
70. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995; 144:157-93.
71. + cells to support autoantibody synthesis. Arth Rheum 1990; 33:1216-25.
72. Mignotte B, Vayssiere J-L. Mitochondria and apoptosis. Eur J Biochem 1998; 252:1-15.
73. Lorenz H-M, Herrmann M, Kalden JM. The pathogenesis of autoimmune diseases. Scand J Clin Laboratory Invest 2001; 61 (Suppl. 235):16-26.
74. Bijl M, Limburg PC, Kallenberg CGM. New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis. Neth J Med 2001; 59:66-75.
75. Courtney PA, Crockard AD, Williamson K et al. Increased peripheral blood neutrophils in systemic lupus erythematosus, relations with disease activity, antibodies to double stranded DNA and neutropenia. Ann Rheum Dis 1999; 58:1241-50.
76. Bijl M, vanLopik T, Limburg PC. Do elevated levels of serum soluble fas contribute to the persistance of activated lymphocytes in systemic lupus erythematosus? J Autoimmunity 1998; 11:457-63.
77. Gordon C, Salmon M. Update on systemic lupus erythematosus: autoantibodies and apoptosis. Clin Med 2001; 1:10-4.
78. Funauchi M, Sugiyama M, Sukyoo B, Ikoma S, Ohno M, Kinoshita K, Kanamaru A. A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Lupus 2001; 10:284-8.
79. Hermann M, Voll RE, Zopller OM et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophage from patients with systemic lupus erythematosus. Arth Rheum 1998; 41:1241-50.
80. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease. A problem of defective apoptosis. Arth Rheum 1994; 37:1415-20.
81. Emlen W, Neibur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152:3685-92.
82. Casiano CA, Tan EM. Recent developments in the understanding of antinuclear antibodies. Int Arch Allergy Immunol 1996; 114:308-13.
83. Cabral AR, Alarcon-Segovia D. Autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 1997; 9:387-92.
84. Vaishnaw AK, McNally JD, Elkon KB. Apoptosis in rheumatic diseases. Arth Rheum 1997; 40:1917-27.
85. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86:69-74.
86. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177:1367-81.
87. Gilbert D, Brard F, Jovelin F, Tron F. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus? J Autoimmunity 1996; 9:247-57.
88. Morioka T, Fujigaki Y, Batsford SR et al. Anti-DNA antibody derived from a systemic lupus erythematosus patient forms histone-DNA-anti-DNA complexes that bind to rat glomeruli in vivo. Clin Exp Immunol 1996; 104:92-6.
89. Gruschwitz MS, Shoenfeld Y, Krupp M et al. Antinuclear antibody profile in UCD line 200 chickens: a model for progressive systemic sclerosis. Int Arch Allergy Immunol 1993; 100:307-13.
90. Reimer G, Scheer U, Peters JM, Tan EM. Immunolocalization and partial characterization of a nucleolar antigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. J Immunol 1986; 137:3802-8.
91. Garg DK, Ali R. Reactive oxygen species modified polyguanylic acid: immunogenicity and implications for systemic autoimmunity. J Autoimmunity 1998; 11:371-8.
92. Schorer AE, Wickham NW, Watson KV. Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation. Br J Haematol 1989; 71:399-407.
93. Zouali M. The structure of human lupus anti-DNA antibodies. Methods 1997; 11:27-35.
94. Klinman DM, Steinberg AD. Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 1987; 165:1755-60.
95. Bloom DD, Davignon JL, Cohen PL, Eisenberg RA, Clarke SH. Overlap of the anti-Sm and anti-DNA responses of MRL/MP-lpr/lpr mice. J Immunol 1993; 150:1579-90.
96. Radic MZ, Mascelli MA, Erikson J, Shan H, Weigert M. Ig H and L chain contributions to autoimmune specificities. J Immunol 1991; 146:176-82.
97. Zouali M, Druilhe P, Gentilini M, Eyquem A. High titres of anti-T antibodies and other haemagglutins in human malaria. Clin Exp Immunol 1982; 50:83-91.
98. Fredriksen K, Osei A, Sundsfjord A, Traavik T, Rekvig OP. On the origin of anti-double stranded (ds) DNA antibodies: systemic lupus erythematosus related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZW x NZW) F1 hybrids, but not in normal mice. Eur J Immunol 1994; 24:66-70.